BR9302427A - Processo estereo seletivo para a preparacao de um derivado de riboturanosila - Google Patents

Processo estereo seletivo para a preparacao de um derivado de riboturanosila

Info

Publication number
BR9302427A
BR9302427A BR9302427A BR9302427A BR9302427A BR 9302427 A BR9302427 A BR 9302427A BR 9302427 A BR9302427 A BR 9302427A BR 9302427 A BR9302427 A BR 9302427A BR 9302427 A BR9302427 A BR 9302427A
Authority
BR
Brazil
Prior art keywords
riboturanosil
derivative
preparation
stereo process
selective stereo
Prior art date
Application number
BR9302427A
Other languages
English (en)
Portuguese (pt)
Inventor
Ta-Sen Chou
Charles David Jones
Thomas Edward Mabry
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9302427A publication Critical patent/BR9302427A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/02—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9302427A 1992-06-22 1993-06-21 Processo estereo seletivo para a preparacao de um derivado de riboturanosila BR9302427A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90230692A 1992-06-22 1992-06-22

Publications (1)

Publication Number Publication Date
BR9302427A true BR9302427A (pt) 1994-01-11

Family

ID=25415658

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9302427A BR9302427A (pt) 1992-06-22 1993-06-21 Processo estereo seletivo para a preparacao de um derivado de riboturanosila

Country Status (15)

Country Link
US (1) US5453499A (cg-RX-API-DMAC7.html)
EP (1) EP0576231B1 (cg-RX-API-DMAC7.html)
JP (1) JP3291071B2 (cg-RX-API-DMAC7.html)
KR (1) KR940000475A (cg-RX-API-DMAC7.html)
AT (1) ATE153669T1 (cg-RX-API-DMAC7.html)
BR (1) BR9302427A (cg-RX-API-DMAC7.html)
CA (1) CA2098887C (cg-RX-API-DMAC7.html)
DE (1) DE69311000T2 (cg-RX-API-DMAC7.html)
DK (1) DK0576231T3 (cg-RX-API-DMAC7.html)
ES (1) ES2103433T3 (cg-RX-API-DMAC7.html)
GR (1) GR3023911T3 (cg-RX-API-DMAC7.html)
HU (1) HU214030B (cg-RX-API-DMAC7.html)
IL (1) IL106075A (cg-RX-API-DMAC7.html)
MX (1) MX9303713A (cg-RX-API-DMAC7.html)
TW (1) TW224102B (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100449618B1 (ko) * 1998-03-27 2004-11-16 부광약품 주식회사 2'-플루오로-5-메틸-β-L-아라비노푸라노실유리딘의 제조방법
US7214791B2 (en) * 2004-07-01 2007-05-08 Shenzhen Hande Technology Co., Ltd. Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material
CN101023094B (zh) 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
KR100578616B1 (ko) * 2004-07-23 2006-05-10 한미약품 주식회사 Ｄ-에리트로-2,2-다이플루오로-2-데옥시-1-옥소라이보스화합물의 제조방법
KR100699099B1 (ko) * 2004-07-29 2007-03-22 한미약품 주식회사 1-α-할로-2,2-다이플루오로-2-데옥시-Ｄ-라이보퓨라노스유도체 및 이의 제조방법
BRPI0513783A (pt) 2004-07-29 2008-05-13 Hanmi Pharm Ind Co Ltd derivados 1-(alfa)-halo-2, 2-diflúor-2-desóxi-d-ribofuranose e processo para a sua preparação
CN101437524B (zh) * 2004-09-14 2012-01-11 法莫赛特股份有限公司 2＇-氟-2＇-烷基-取代的或其它任选取代的呋喃核糖基嘧啶和嘌呤及其衍生物的制备
WO2006031725A2 (en) 2004-09-14 2006-03-23 Pharmasset, Inc. Preparation of 2'­fluoro-2'- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
AT502221A1 (de) * 2005-07-20 2007-02-15 Pharmacon Forschung & Beratung Gmbh Homogemcitabine, verfahren zu ihrer herstellung sowie deren verwendung
KR100858842B1 (ko) 2007-03-23 2008-09-22 동우신테크 주식회사 키랄아민을 이용한 광학활성 옥소라이보스유도체의제조방법
WO2008117955A1 (en) * 2007-03-23 2008-10-02 Dongwoo Syntech Co., Ltd. Process for preparing of 2'-deoxy-2'2'-difluorocytidine
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
BRPI0923815A2 (pt) * 2008-12-23 2015-07-14 Pharmasset Inc Síntese de nucleosídeos de purina
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
TWI598358B (zh) 2009-05-20 2017-09-11 基利法瑪席特有限責任公司 核苷磷醯胺
PL3290428T3 (pl) 2010-03-31 2022-02-07 Gilead Pharmasset Llc Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
LT2609923T (lt) 2010-03-31 2017-09-11 Gilead Pharmasset Llc (s)-izopropilo 2-(((s)-(perfluorfenoksi)(fenoksi)fosforil)amino)-propanoato kristalinimo būdas
US8841275B2 (en) 2010-11-30 2014-09-23 Gilead Pharmasset Llc 2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
SI3038601T1 (sl) 2013-08-27 2020-07-31 Gilead Pharmasset Llc Formulacija kombinacije dveh protivirusnih spojin
CN106317147B (zh) * 2015-07-06 2018-11-27 扬州硒瑞恩生物医药科技有限公司 核苷类化合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3277077A (en) * 1964-06-03 1966-10-04 Merck & Co Inc 3-deoxy ribofuranosyl halides
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
US5256797A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for separating 2-deoxy-2,2-difluoro-D-ribofuranosyl alkylsulfonate anomers
US5256798A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
US5252756A (en) * 1992-06-22 1993-10-12 Eli Lilly And Company Process for preparing beta-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl-arylsulfonates

Also Published As

Publication number Publication date
HU214030B (en) 1997-12-29
CA2098887A1 (en) 1993-12-23
JP3291071B2 (ja) 2002-06-10
DE69311000T2 (de) 1997-11-27
IL106075A (en) 2000-12-06
HUT64550A (en) 1994-01-28
CA2098887C (en) 2003-10-28
HU9301828D0 (en) 1993-09-28
TW224102B (cg-RX-API-DMAC7.html) 1994-05-21
JPH0656863A (ja) 1994-03-01
MX9303713A (es) 1994-05-31
DK0576231T3 (da) 1997-08-25
IL106075A0 (en) 1993-10-20
KR940000475A (ko) 1994-01-03
ATE153669T1 (de) 1997-06-15
US5453499A (en) 1995-09-26
DE69311000D1 (de) 1997-07-03
ES2103433T3 (es) 1997-09-16
GR3023911T3 (en) 1997-09-30
EP0576231B1 (en) 1997-05-28
EP0576231A1 (en) 1993-12-29

Similar Documents

Publication Publication Date Title
BR9302427A (pt) Processo estereo seletivo para a preparacao de um derivado de riboturanosila
FI890282L (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI905535A7 (fi) Menetelmä havupuiden monistamiseksi somaattisella embryogeneesillä
DK146489A (da) Fremgangsmaade til fremstilling af 2',3'-dideoxy-2',3'-didehydronucleosider
FI873350A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
FI883603A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
ATE121008T1 (de) Zweistufiges verfahren zum herstellen starker, dünner schlauchblasfolien.
FI880467A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
HUT45499A (en) Process for producing optically active 1,4-dihydropyridine derivatives
AU7585294A (en) Method for reproducing conifers by somatic embryogenesis
GR1000467B (el) Μεθοδος παρασκευης τρικυκλικων παραγωγων 3-οξο-προπανονιτριλιου.
PT88493A (pt) Process for preparing milbemycin derivatives useful as antiparasitic agents
GR3022477T3 (en) Stereoselective process for preparing beta-anomer enriched 2-deoxy-2, 2-difluoro-d-ribofuranosyl-3, 5-hydroxy protected-1-alkyl and aryl sulfonate intermediates.
FI883248A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3,5-dihydroksikarboksyylihappojohdannaisten valmistamiseksi
DE3750396D1 (de) Optisch aktive 2,3-Dihydrobenzoxazinderivate und Verfahren zu deren Herstellung.
FI850994A7 (fi) Menetelmä uusien 1,2,4 -triatsasykloalkadieenijohdannaisten valmistamiseksi.
FI911282L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 3,4-dihydroksi-2,5-dihydrofuranonien valmistamiseksi
NO865179D0 (no) Fremgangsmaate for fremstilling av 2-klor-12-(3-dimethylamino-2-methylpropyl)-12h-dibenzo(d,g)(1,3,6)dioxazociner.
ATE128113T1 (de) Calicheamicinon, dessen abkömmlinge und analogen und verfahren zu deren herstellung.
HUT42075A (en) Process for producing 2,2-comma above-bi/1h-imidazol/ derivatives
DK700688D0 (da) Fremgangsmaade til fremstilling af 2,4- eller 2,4,5,-substituerede 6-hydroxypyrimidiner
DE3768617D1 (de) Verfahren zur herstellung von 2,4-diamino-3-oxy-pyrimidin-derivaten.
FI952462L (fi) Menetelmä 1,3-oksatsolidin-5-karboksyylihapon valmistamiseksi
KR870700627A (ko) 세팔로스포린 유도체의 신규 제조방법
DE3586910D1 (de) 1,4-benzochinon-derivate und benzol-derivate und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
CKFC Appeal: appeal against refusal